Trial Profile
A phase IIa trial investigating the efficacy and safety of GX-051 in head and neck cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs GX 051 (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 25 Feb 2016 New trial record